Metagenomi Inc (NASDAQ: MGX) kicked off on Tuesday, up 5.74% from the previous trading day, before settling in for the closing price of $2.09. Over the past 52 weeks, MGX has traded in a range of $1.85-$12.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 3569.20%. While this was happening, its average annual earnings per share was recorded 85.26%. With a float of $18.54 million, this company’s outstanding shares have now reached $37.47 million.
Let’s determine the extent of company efficiency that accounts for 236 employees. In terms of profitability, gross margin is 91.17%, operating margin of -158.21%, and the pretax margin is -131.0%.
Metagenomi Inc (MGX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Metagenomi Inc is 50.47%, while institutional ownership is 26.04%. The most recent insider transaction that took place on Sep 05 ’24, was worth 18,043. In this transaction Chief Financial Officer of this company sold 6,265 shares at a rate of $2.88, taking the stock ownership to the 63,051 shares. Before that another transaction happened on Feb 13 ’24, when Company’s 10% Owner bought 800,000 for $15.00, making the entire transaction worth $12,000,000. This insider now owns 1,739,175 shares in total.
Metagenomi Inc (MGX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.84 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 85.26% per share during the next fiscal year.
Metagenomi Inc (NASDAQ: MGX) Trading Performance Indicators
Take a look at Metagenomi Inc’s (MGX) current performance indicators. Last quarter, stock had a quick ratio of 5.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.52, a number that is poised to hit -0.78 in the next quarter and is forecasted to reach -2.90 in one year’s time.
Technical Analysis of Metagenomi Inc (MGX)
Looking closely at Metagenomi Inc (NASDAQ: MGX), its last 5-days average volume was 0.42 million, which is a jump from its year-to-date volume of 0.17 million. As of the previous 9 days, the stock’s Stochastic %D was 46.70%. Additionally, its Average True Range was 0.17.
During the past 100 days, Metagenomi Inc’s (MGX) raw stochastic average was set at 9.86%, which indicates a significant decrease from 70.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.75% in the past 14 days, which was lower than the 77.40% volatility it showed in the past 100 days.
However, in the short run, Metagenomi Inc’s stock first resistance to watch stands at $2.35. Second resistance stands at $2.49. The third major resistance level sits at $2.64. If the price goes on to break the first support level at $2.06, it is likely to go to the next support level at $1.91. Now, if the price goes above the second support level, the third support stands at $1.77.
Metagenomi Inc (NASDAQ: MGX) Key Stats
The company with the Market Capitalisation of 82.72 million has total of 37,429K Shares Outstanding. Its annual sales at the moment are 44,760 K in contrast with the sum of -68,260 K annual income. Company’s last quarter sales were recorded 20,010 K and last quarter income was -10,740 K.
